Ben-Shabat, S.; Yarmolinsky, L.; Sharon, N.; Zeadnaa-Aldda, T.; Dayan, S.; Khalfin, B.; Fleisher-Berkovich, S.
Cannabinoids, the Blood–Brain Barrier, and Neurodegeneration: Mechanisms, Dysregulation, and Therapeutic Perspectives. Biomolecules 2026, 16, 225.
https://doi.org/10.3390/biom16020225
AMA Style
Ben-Shabat S, Yarmolinsky L, Sharon N, Zeadnaa-Aldda T, Dayan S, Khalfin B, Fleisher-Berkovich S.
Cannabinoids, the Blood–Brain Barrier, and Neurodegeneration: Mechanisms, Dysregulation, and Therapeutic Perspectives. Biomolecules. 2026; 16(2):225.
https://doi.org/10.3390/biom16020225
Chicago/Turabian Style
Ben-Shabat, Shimon, Ludmila Yarmolinsky, Nitzan Sharon, Taima Zeadnaa-Aldda, Shir Dayan, Boris Khalfin, and Sigal Fleisher-Berkovich.
2026. "Cannabinoids, the Blood–Brain Barrier, and Neurodegeneration: Mechanisms, Dysregulation, and Therapeutic Perspectives" Biomolecules 16, no. 2: 225.
https://doi.org/10.3390/biom16020225
APA Style
Ben-Shabat, S., Yarmolinsky, L., Sharon, N., Zeadnaa-Aldda, T., Dayan, S., Khalfin, B., & Fleisher-Berkovich, S.
(2026). Cannabinoids, the Blood–Brain Barrier, and Neurodegeneration: Mechanisms, Dysregulation, and Therapeutic Perspectives. Biomolecules, 16(2), 225.
https://doi.org/10.3390/biom16020225